DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Dapivirine is an investigational drug.
There have been 40 clinical trials for Dapivirine. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2016.
The most common disease conditions in clinical trials are HIV Infections, Acquired Immunodeficiency Syndrome, and Infection. The leading clinical trial sponsors are International Partnership for Microbicides, Inc., National Institute of Allergy and Infectious Diseases (NIAID), and National Institutes of Health (NIH).
There are thirty US patents protecting this investigational drug and seven hundred and one international patents.
Recent Clinical Trials for Dapivirine
|Safety and Drug Detection Study of Dapivirine Vaginal Ring and Oral TRUVADA® in Breastfeeding Mother-Infant Pairs||National Institute of Allergy and Infectious Diseases (NIAID)||Phase 3|
|Randomized, Open Label Safety Trial of Dapivirine Vaginal Ring and Oral TRUVADA® Use in Pregnancy||National Institute of Allergy and Infectious Diseases (NIAID)||Phase 3|
|Evaluating the Safety of and Adherence to a Vaginal Matrix Ring Containing Dapivirine and Oral Emtricitabine/Tenofovir Disoproxil Fumarate in an Adolescent and Young Adult Female Population||National Institute of Allergy and Infectious Diseases (NIAID)||Phase 2|
Top disease conditions for Dapivirine
Top clinical trial sponsors for Dapivirine
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Dapivirine||Start Trial||Combination therapy intravaginal rings||International Partnership for Microbicides, Inc. (Silver Spring, MD)||Start Trial|
|Dapivirine||Start Trial||HIV replication inhibiting pyrimidines||Janssen Pharmaceutica NV (Beerse, BE)||Start Trial|
|Dapivirine||Start Trial||HIV inhibiting pyrimidine derivative||Janssen Pharmaceutica, Inc. (New Brunswick, NJ)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Dapivirine||African Regional IP Organization (ARIPO)||1610||2021-08-13||Start Trial|
|Dapivirine||African Regional IP Organization (ARIPO)||2109||2021-08-13||Start Trial|
|Dapivirine||African Regional IP Organization (ARIPO)||2296||2021-08-13||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|